TELA Bio (TELA) Operating Margin (2018 - 2026)
TELA Bio's (TELA) quarterly Operating Margin came in at 55.23% in Q1 2026, up 132.0% year-on-year from 23.81% in Q1 2025, and down 73.37% quarter-over-quarter from 31.86% in Q4 2025.
TELA Bio (TELA) Operating Margin (2018 - 2026) Analysis & Trends
TELA Bio's Operating Margin history runs 9 years deep, the most recent figure standing at 55.23% for Q1 2026.
- On a quarterly basis, Operating Margin rose 132.0% year-over-year to 55.23% in Q1 2026; TTM through Mar 2026 was 41.84%, a 1400.0% increase from a year earlier, with the FY2025 full-year figure at 42.05%, up 718.0% from the prior year.
- Operating Margin slipped to 55.23% in Q1 2026 per TELA's latest filing, from 31.86% in the prior quarter.
- Across five years, Operating Margin topped out at 29.07% in Q1 2024 and bottomed at 119.6% in Q1 2022.
- The 5-year median for Operating Margin is 67.64% (2023), against an average of 65.46%.
- Across the five-year window, Operating Margin jumped 6543 bps in 2024 and tumbled 2748 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 81.22% in 2022, then increased by 11 bps to 72.23% in 2023, then surged by 34 bps to 47.33% in 2024, then surged by 33 bps to 31.86% in 2025, then tumbled by 73 bps to 55.23% in 2026.
- Per Business Quant, the three latest TELA Operating Margin figures stand at 55.23% (Q1 2026), 31.86% (Q4 2025), and 36.51% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -55.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.23% |
| Dec 31, 2025 | -31.86% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | -56.54% |
| Dec 31, 2024 | -47.33% |
| Sep 30, 2024 | -49.40% |
| Jun 30, 2024 | -71.90% |
| Mar 31, 2024 | -29.07% |
| Dec 31, 2023 | -72.23% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -71.49% |
| Mar 31, 2023 | -94.50% |
| Dec 31, 2022 | -81.22% |
| Sep 30, 2022 | -85.02% |
| Jun 30, 2022 | -98.38% |
| Mar 31, 2022 | -119.60% |
| Dec 31, 2021 | -91.40% |
| Sep 30, 2021 | -94.29% |
| Jun 30, 2021 | -96.73% |